The present study aims to evaluate the effectiveness of pimavanserin in patients with psychosis in Parkinson's disease. Its effects on the clinical picture of psychosis were evaluated, as well as its adverse reactions and influences on patients' quality of life. This is a Systematic Literature Review of a qualitative nature, with a search strategy for the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) and Critical Appraisal Skill Program (CASP) methodological evaluation, analyzing a total of 8 articles. Articles were searched in PubMed databases, excluding simple literature reviews and incomplete articles. Those published in the last 10 years (2013-2023) and available in English were included. After a systematic analysis of the studies, it is concluded that pimavanserin demonstrates effectiveness in reducing hallucinogenic and delusional symptoms. Furthermore, it was found that the combination of pimavanserin with other medications, especially clozapine, showed promise in terms of safety, especially in improving cognitive functions. Patients showed improvements in the quality of sleep and wakefulness, in addition to a significant reduction in symptoms. Furthermore, side effects include pneumonia, episodes of syncope, obstructive pulmonary disease, pulmonary embolism and deep vein thrombosis. It is expected that future studies will continue to develop more intervention research on the effectiveness of the medication in treating Parkinson's disease, highlighting benefits and improvements in patients' quality of life through the use of the drug in medical practice.
A perda progressiva de massa muscular caracteriza a Sarcopenia, sendo cada vez mais acentuada com a progressão da idade, propiciando inúmeros outros problemas de saúde desencadeados pelo quadro de sarcopenia. O presente estudo trata de uma revisão integrativa de literaturas que tenham por objetivo avaliar os benefícios do treinamento de força no estadiamento e regressão da sarcopenia em idosos, publicados entre o período de 2009 a 2021, disponibilizados em Português, Inglês. Foram selecionados artigos disponíveis na base de dados PubMed, e levado em conta pesquisa de abordagem para o estudo de testes controlados e aleatórios, meta-análises e ensaios clínicos. Para avaliar qualidade metodológica, utilizou-se o Critical Appraisal Skill Programme (CASP) adaptado, que abrangeu 10 itens a serem analisados. A sarcopenia apresenta prevalência mais frequente nas pessoas com mais de 60 anos tendo como um dos métodos de combate mais eficientes o treinamento de força. Além disso, envolve também melhoria de vida para os idosos acometidos por essa doença.
20 October 2023 in Research, Society and Development
The present study aims to evaluate the effectiveness of the ketogenic diet in improving the quality of life of patients with West Syndrome, in the control of spasms and convulsions, the benefits of its use alone and as an adjunct to conservative therapies, and its short-term consequences. and long term regarding its tolerance and side effects. This is a Systematic Literature Review of a qualitative nature, with a search strategy for the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) and Critical Appraisal Skill Program (CASP) methodological evaluation, analyzing a total of 6 articles. The articles were searched in the PubMed and SciELO databases, excluding simple literature reviews. Articles published in the last 10 years (2013-2023) and available in English were included. After a systematic analysis of the studies, it appears that the ketogenic diet is effective in reducing infantile spasms, especially in cases refractory to combined drug treatments. In addition, the side effects and relapses to the condition were lower than in patients who used adrenocorticotropic hormone. The Atkins diet approach has also been successful in stopping spasms. The ketogenic diet was well tolerated, with minimal side effects when combined with Vigabatrin. Side effects included increased triglycerides and ketone body. It is hoped that future studies will continue to highlight the benefits and improvements in the quality of life of patients with West Syndrome.